Mahmoud S Elkotamy

8PUBLICATIONS
16CO-AUTHORS
Molecular targetsBiomolecular modelling and designCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 22, 2026
Identification of Sulfonamide-Based Thiazolidine-2,4-Dione Derivatives as VEGFR-2 and Tumor-Associated hCA IX Inhibitors With Hypoxia-Targeted Anti-Colorectal Cancer Activity.

|Jun 05, 2026
Unlocking the antidiabetic potential of novel pyrazole-triazole hybrids through synthesis, dual α-amylase/α-glucosidase inhibition, multiscale biological evaluation, and molecular dynamics studies.

|May 15, 2026
Design and Synthesis of Indole-Based Imidazo[1,2-a]pyridine Derivatives as Antiseizure Candidates: Evaluation in Chemically Induced Seizure Models and In Vitro Antioxidant Assays.

|Apr 24, 2026
Pyrazole-triazole hybrids as kinase-triad inhibitors: a triple-target strategy for synergistic anticancer therapy.

|Apr 22, 2026
Structure-based design of potent pyrazolo[1,5-a]pyrimidine CDK4/6 inhibitors: biological evaluation and computational validation.

|Oct 28, 2024
Molecular docking, DFT and antiproliferative properties of 4-(3,4-dimethoxyphenyl)-3-(4-methoxyphenyl)-1-phenyl-1H-pyrazolo[3,4-b]pyridine as potent anticancer agent with CDK2 and PIM1 inhibition potency.

Faizah A Binjubair, Basma S Almansour, Noha I Ziedan

Pageof 2

Frequent Collaborators

3 joint publications

Wagdy M Eldehna

2 joint publications

Mohamed K Elgohary

2 joint publications

Abdulrahman A Almehizia

2 joint publications

Ahmed M Naglah